Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07277998
Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis (RegenOSF)
Clinical Efficacy of Alternating Intralesional Triamcinolone Acetonide and Platelet-Rich Plasma Compared to Triamcinolone Alone in Patients With Oral Submucous Fibrosis: A Two-Arm Interventional Clinical Trial
Sponsor: Karachi Medical and Dental College
Conditions
Oral Submucous Fibrosis
Interventions
Platelet-Rich Plasma (PRP) Injections Triamcinolone Acetonide
Updated 1 time since 2026 Last updated: Dec 10, 2025 Started: Mar 31, 2026 Primary completion: Jul 31, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Oral Submucous Fibrosis, this trial is actively recruiting participants. The trial is conducted by Karachi Medical and Dental College and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Karachi Medical and Dental College
Data source: Karachi Medical and Dental College
For direct contact, visit the study record on ClinicalTrials.gov .